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An in vivo study was conducted to determine the effect of tamoxifen-loaded solid lipid nanoparticle on 
LA7 cell-induced rat mammary tumor. After the first tumors appearance, the thirty rats were divided into 
five groups. Group I served as normal control animal. The other four groups were mammary gland 
tumor-bearing animals treated with soy oil (Group II), tamoxifen (TAM) dissolved in soy oil (Group III), 
tamoxifen-loaded solid lipid nanoparticle (Group IV) and solid lipid nanoparticle (SLN) (Group V) 
dispersed in soy oil. The effect of TAM-loaded SLN in the reduction of tumor size was greater than that 
of free TAM. The transmission electron microscope analysis showed apoptosis in TAM-loaded SLN and 
free TAM treatment groups. After treatment, the rats treated with TAM-loaded SLN showed decreases in 
concentration of serum enzymes. In conclusion, the study suggests that TAM-loaded SLN is very 
effective for treatment of rat mammary gland tumors and breast cancers. 
 





In chemotherapy, the aims of the treatment are to contract 
the primary tumors, slow tumor growth, destroy cancer 
cells that might have been metastasized and control 
malignancy (Padmavathi et al., 2006). Tamoxifen (TAM) 
has long been the only option for the treatment of 
hormone dependent breast cancer. The antitumor effect 
of tamoxifen is related to growth arrest and induction of 
apoptosis (Manlekar and Kong, 2001) mediated by 
linkage to the  intracellular  estrogen  receptor  on  breast 
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1993), inhibition of protein kinase C  (O’Brian et al., 1985) 
and its binding to calmoduline (Lam, 1984). There are 
side-effects to the use of tamoxifen; among them are 
development of liver cancers, increasing blood clothing, 
retinopathy and corneal opacities (Han and Liehr, 1992; 
Fisher et al., 1994; Memisoglu-Bilensoy et al., 2005). Due 
to these side-effects, the colloidal delivery systems were 
suggested to be the best way of delivery of tamoxifen for 
long-term chemotherapy of breast cancers. Solid lipid 
nanoparticles (SLNs) have been recommended as the 
carrier in these drug delivery systems. The main benefit 
of SLN is that it is non toxic, has good bioavailability, not 
easily degraded and can be produced on a large scale 
(Jores et al., 2005; Yuan et al., 2007). SLNs also have 
been recommended to substitute as drug delivery syste-
ms to approved polymeric nanoparticles (Luo et al., 
2006). Carcinogenicity in animal models has been widely 
used in development of new anticancer therapeutic 
methods (Kim et al., 2006). The aim of this study is to 
determine the effect of TAM loaded SLN on the size and 
ultrastructure of tumor and biochemical  serum  factors of 
the rat mammary gland tumor. 




MATERIALS AND METHODS 
 
Cells, chemicals and animals 
 
LA7, rat mammary gland tumor cells was a gift from Dr Teo Guan 
Young (Institute Bioscience, UPM). The cells were maintained at 
37°C in a humidified atmosphere of 5% CO
2
 in Dulbecco’s Modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS), 100 µg/ml streptomycin and 100 IU/ml penicillin. 
Softisan
®
 154 (S154) or hydrogenated palm oil, was a gift from 
CONDEA (Witten, Germany). Lipoid S100 (soy lecithin) was a gift 
from Lipoid KG (Ludwigshafen, Germany). Thimerosal, sorbitol and 
tamoxifen were purchased from Sigma.  
Thirty virgin female Sprague-Dawley rats aged 6 to 8 weeks, 
weighing 180 - 200 g were purchased from Sapphire Enterprise, 
Malaysia. The animals were housed at two rats per plastic cages 
and allowed to acclimate in standard conditions (under a 12 h 
light/dark cycle) for one week. The rats were given free access to 
distilled water and commercialized food throughout the experiment. 
 
 
Preparation of cancer cells for injection 
 
When cells reached 90% confluence, the medium was replaced 
with fresh medium to remove dead and detached cells. The next 
day, the medium was removed and cells were washed with 
phosphate buffered saline (PBS). A minimum amount of trypsin-
ethylenediaminetetraacetic acid (EDTA) was added to detach the 
cells. The cells were obtained immediately by centrifuging at 100 g 
for 10 min at 4°C, washed twice with PBS, dispersed in PBS and 
counted using a hemocytometer. Trypan blue staining was used to 
exclude dead cells. Eventually, cells were suspended in a volume 




Preparation of SLN and TAM-loaded SLN 
 
SLN was prepared using the high pressure homogenization (HPH) 
technique (Schubert and Müller-Goymann, 2005). Briefly, 70 g palm 
oil (S154) and 30 g soy lecithin (S100) were weighed, mixed and 
ground in a ceramic crucible and then heated up to 65 - 70°C until a 
clear yellowish solution was obtained. A solution consisting of 1ml 
oleyl alcohol, 0.005 g thimerosal, 4.75 g sorbitol and 89.25 ml 
bidistilled water was added to each of the lipid matrices. The 
mixtures were stirred on a magnetic stirrer using a teflon coated 
magnet, for 30 min at room temperature.  
The lipophilic drug model, TAM, with concentration of 10 mg was 
dissolved in 1 ml oleyl alcohol and mixed with 50 mg SLN using an 
Ultra Turrax
® 
(Ika, Staufen Germany) at 13000 rpm for 10 min. The 
mixture of TAM-SLN was then incubated at 50 - 60°C while stirring 
overnight with a teflon coated magnet at 500 rpm and then exposed 
to air until solidification.  
 
 
Mammary tumor induction 
 
Twenty-four rats were anesthetized using an intraperitoneal 
injection with a mixture of ketamine-HCl (150 mg/Kg body weight) 
and xylazine (10 mg/Kg body weight). The LA7 cells (300 µl 
containing 6 × 10
6
 cells) were inoculated subcutaneously into the 
mammary fat pad (right flank) of each rat using a tuberculin (TB) 










group comprised untreated normal healthy rats and served as the 
negative control group, while the second group comprised rats 
induced to develop mammary gland tumor and served as the 
positive control. This group of rats received a single dose of 1 ml of 
soy oil and was ascribed as untreated. The third group of mammary 
gland tumor-bearing rats was treated weekly with 10 mg TAM 
dissolved in 1 ml soy oil and assigned the group TAM. The fourth 
group also comprised the mammary gland tumor-bearing rats and 
each rat received 10 mg TAM-loaded SLN (a total of 10 mg TAM 
loaded in 50 mg SLN dispersed in 1 ml soy oil). As a result, this 
group was assigned the group TAM-SLN. Also, the fifth group 
comprised rats with mammary gland tumor that received 50 mg 
TAM-free SLN dispersed in 1 ml soy oil and assigned the group 
SLN. The treatments were given orally for 4 consecutive weeks to 
the animals using gastric intubations. The experimental procedure 
was approved by the Institutional Animal Care and Use Committee 
(IAUC) of the Faculty of Veterinary Medicine at University Putra 
Malaysia (UPM), and research was conducted according to the 





All animals were monitored for the development of mammary gland 
tumor mass by palpation, rolling up the skin and pinching the mass 
between the fingers (Perumal et al., 2005). The presence of tumor 
was confirmed by X-ray imaging. The animals were weighed twice 
weekly and the tumors measured using a digital caliper. The radius 
of individual palpable tumor was horizontally and vertically 
measured and averaged. The two dimensional tumor areas were 
calculated as an ellipse. The volume of tumor (V) was calculated by 
the formula given by Carlsson et al. (1983): V = ab
2
/2. Where, ‘a’ is 
the longest diameter and ‘b’ is the shortest diameter of the tumor. 






At the end of the study, the rats were scarified and examined for 
tissue abnormalities. Samples of tumor mass from all groups were 
immediately fixed in 10% formalin overnight, embedded in paraffin, 
cut into 5 µm sections, placed on slides and stained with 
Hematoxylin-Eosin (H&E). The tissues sections were viewed under 
a light microscope (Nikon ECLIPSE TS 100, Japan). The number of 
apoptotic cells was determined in the sections. The apoptotic cells 
were recognized among them, as cells with nuclei containing 
marginated chromatin, homogeneously staining chromatin, dense 
staining nuclear fragments and apoptotic bodies (membrane-bound 
structures containing chromatin). Ten fields were randomly chosen 
from each slide and the number of apoptotic cells were enumerated 




Transmission electron microscope  
 
The ultrastructure of apoptotic cells was examined through trans-
mission electron microscope (TEM). Briefly, the mammary gland 
tissue sections were fixed in 2.5% glutaraldehyde in 0.1 M PBS, pH 
= 7.4 for 1 h at 4°C. After fixation, the sections were washed in the 
same buffer and post-fixed with 1% OsO4 in 0.1 M PBS for 2 h. The 
fixed sections were dehydrated in a graded series of acetone, 
embedded in resin (100%) and polymerized in oven at 60°C for 48 
h.  Ultrathin  sections  were  cut  with  a  diatom knife on ultra-
microtome (Leica UCT), collected on copper grids and stained with 
uranyl acetate and lead citrate. The sections were viewed under a 
transmission electron microscope (Hitachi H-7100, Japan). 




Table 1. Effect of treatment with TAM, TAM loaded SLN and SLN on animal body weight (g). 
 
Group 
Drug treated days 
0 7 14 28 
Control 184.00±14.5 195.00±16.7 204.33±18.86 211.00±21.51 
Untreated 164.68±21.2 174.10±20.7 181.34±21.72 184.57±23.93 
SLN 165.22±25.9 180.02±22.24 189.90±22.60 194.27±22.69 
TAM 177.97±22.6 183.65±11.00 190.26±11.17 196.33±11.00 
TAM-SLN 174.02±20.0 181.75±17.80 188.42±17.94 193.88±19.83 
 




Serum biochemical parameters  
 
Blood samples were collected from healthy control and tumor-
bearing rats by cardiac puncture using 23 or 26 G needles before 
and after tumor development. The blood samples were allowed to 
clot at room temperature and centrifuged at 1000 g for 10 min, and 
serum were separated and analyzed for lactate dehydrogenase 
(LDH), alkaline phosphatase (ALP) and alanine aminotransferase 
(ALT) by a chemistry analyzer (HITACHI, 902, Japan) using standard 





The data obtained were subjected to statistical analysis. The diffe-
rences in means among the groups were expressed as mean ± 
standard deviation. All the data were subjected to one-way analysis 
of variance (ANOVA) followed by Post Hoc multiple comparison and 
Duncan test after verification of the normal distribution of the data. 
The Statistical Package for the Social Sciences (SPSS) version 
15.0 (SPSS 2006) was used to perform all statistical tests and p-







Palpation of mammary gland was performed by rolling up 
the skin and pinching the mass between the fingers 
(Perumal et al., 2005) in 6 - 8 early days after injection of 
LA7 cells. The tumors that developed in 80% of the rats 
were soft, rubbery and as they grew they become 
irregular, lobulated and more adhesive to the skin than to 
the body wall (data not shown).  
 
 
Body weight, tumor size and volume 
 
The results showed that treatment with SLN, TAM and 
TAM-loaded SLN did not negatively affect the body 
weights of these animals (Table 1). The body weight of all 
animals increased during the study period and there was 
no significant (p > 0.05) difference among treatment 
groups.  
The tumor growth was measured weekly using a 
caliper. The tumors in the control and SLN groups grew 
rapidly, reaching an average volume of 1564 ± 540 mm
3
 
and 2024 ± 708 mm
3
, respectively by day 28. Groups 
TAM and TAM-loaded SLN showed a significant (P < 
0.05) reduction in their tumor volume when compared 
with the untreated as positive control and SLN treated 
animals. The TAM-loaded SLN treatment also had 
greater reduction (87%) in the tumor volume than free 
TAM (74%) treatment (Table 2).  
 
 
Blood biochemical parameters 
 
In this study, blood samples were obtained from the rats 
at days 0 and 28 of treatment and were used to deter-
mine biochemical parameters. As it is shown in Table 3 
before treatment at day 0, there was significant increase 
(P < 0.05) in ALP concentrations in experimental groups. 
In our study, the serum ALP concentration decreased 
after 28 days of treatment, and still remained significantly 
higher than the controls. In our study, the serum LDH 
concentrations in all treated rats increased significantly (P 
< 0.05). After 28 days of treatment, only rats treated with 
TAM-loaded SLN showed a decrease in serum LDH 





The histopathological features of tumors that developed 
in rats with mammary gland tumors untreated (Figure 1) 
and treated TAM-free SLN (Figure 2) were reactive 
lymphatic follicular hyperplasia, typical appearance of 
neoplastic cell with invasive features, high mitotic activity 
and necrosis consistent with adenocarcinomas. Histolo-
gical analysis of tumors from tumor-bearing rats showed 
mitosis and treatment with TAM-loaded SLN (Figure 3) 
showed 25 - 50% apoptosis and the mitotic activity was low.  
 
 
Transmission electron microscopy  
 
The TEM examination  showed  the  presence  of  tumor 
cell populations with variable electron density levels 
termed “light” and “dark” cells. The typical morphological 
features of apoptosis include margination and conden-
sation of chromatin, fragmentation of the nucleus and 
formation of apoptotic bodies (Figures 4 - 7). 
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All values are expressed as mean ± standard deviation; 
ab




Table 3. Statues of serum biochemical parameters of animal before and after treatment of animals with 




All values are expressed as mean ± standard deviation; 
ab
Means with the different superscripts are significantly 
different; p < 0.05; *shows significant difference in column at p < 0.05 as compared to before treatment; ALT = 
alanine transaminase; ALP = alkaline phosphatase; LDH = lactic acid dehydrogenase; SLN = solid lipid 







Tumors in the control and SLN groups grew rapidly, while 
groups treated with TAM and TAM loaded SLN showed a 
significant (P < 0.05) reduction in tumor volume. This 
finding is similar to those reported earlier, when TAM 
alone and TAM plus riboflavin, niacin and CoQ10 were 
used (Perumal et al., 2005).  
Blood biochemical parameters can be useful in the 
diagnosis of breast cancers because it can be easily 
done in most diagnostic laboratories. In one study, signifi-
cantly increased ALP was observed in bone and liver 
metastases of breast cancers (Sandhya and Sharma, 
2004). During the treatment period, although the serum 
ALP concentration decreased, it still remained signifi-
cantly higher than the controls. This study suggests that 
TAM treatment did not significantly affect serum ALP 
concentration in tumor bearing rats concurring with a 
previous report (Abdel-Kader and Hemieda, 2007). The 
ALP concentration of TAM-loaded-SLN-treated rats with 
tumor decreased by 20% from the control while that of 
the free TAM-treated group decreased by 4%. It should 
be noted that ALP is not an organ specific enzyme. The 
enzyme is present in many tissues of the body. Thus ALP 
may not be useful in the diagnosis of mammary gland 
tumors. Liver disorders can be determined by serological 
markers such as alanine transaminase. The abnormal 
increase of serum ALT concentrations, may suggest liver 
metastasis (Wang et al., 2006) and hepatotoxicity (Lynch 
et al., 2005). The lack of change in ALT in this study 
suggests that there is no liver metastasis in these rats with 
mammary gland tumor. By the end of the study, the level 
of ALT in the free TAM-treated rats only showed 
significantly increased (P < 0.05) serum ALT. It is 
reported that treatment with TAM can significantly 
increase serum activity of ALT which is correlated with 
hepatotoxicity (Abdel-Kader and  Hemieda,  2007).  How- 
Group 
Serum biomarker 
ALT (U/L) ALP (U/L) LDH (U/L) 


















































































Figure 2. Rat mammary gland tumor after oral treatment with solid lipid nanoparticle showing 






Figure 3. Rat mammary gland tumor treated with tamoxifen showing 
apoptosis (arrow) (H&E, x40). 






Figure 4. Rat mammary gland tumor treated with tamoxifen-loaded SLN showing 






Figure 5. Untreated mammary tumor cells of female Sprague-Dawley rat induced 
with subcutaneous injection of LA7 cells, showing normal structure (thick arrow) 




ever, when TAM is encapsulated in SLN, the same effect 
was not seen, suggesting that loading TAM in SLN had 
eliminated the hepatotoxic effect of the drug. The serum 
LDH concentrations significantly increased in patients with 
endometrial adenocarcinoma, ovarian adenocarcinomas 
and breast cancers (Koukourakis et al., 2008). However, 
this enzyme has been suggested not to be useful in the 
diagnosis of metastatic cancers (Sandhya and Sharma, 
2004). In our study, the rats treated with TAM-loaded 
SLN only showed decrease in serum LDH that reflects 
lower tumor volume resulting in decreased release of 
cytoplasmic   LDH  when  compared  to  the  TAM-treated 
group. Therefore this novel drug delivery may represent a 
useful strategy for cancer treatment.  
The histopathological examination revealed adenocar-
cinomas feature of the mammary gland tumor. In 
adenocarcinoma, malignant tumors are derived glandular 
epithelium and have  an  adenomatous  appearance. The  
 
 






Figure 6. Rat mammary tumor treated with tamoxifen-loaded solid lipid 
nanoparticle, showing early apoptosis (cell shrinkage, chromatin condensation 






Figure 7. Rat mammary tumor treated with tamoxifen showing apoptosis 




epithelium cells are arranged in gland-like structures 
surrounding a lumen. Nucleoli are often prominent and 
mitotic figures are abundant. Necrosis is a common 
feature of adenocarcinomas and the necrotic  tumors  will  
be softer  and  possibly  fluctuant  (Young  and  Hallowes, 
1973) as shown in Figure 3. Although routine light 
microscopy examination has been established as an 
adequate assessment in the diagnosis of the tumor 
mass, TEM allows the view of the cell ultrastructures, 
which could provide detailed  information  on  the  cellular  




changes. Through TEM, programmed cell death or 
apoptosis in the mammary tumor gland of the rats treated 
with TAM (Figure 5) and TAM loaded SLN (Figure 6) may 
be demonstrated. The high percentage of apoptosis in 
group treated with TAM-loaded SLN showed that the 
antitumoral efficacy of tamoxifen is still high even when 
TAM is encapsulated in SLN. 
Apoptosis is ‘silent death’ and happens without inflam-
mation, because dying cells are phagocytosed by 
intraepithelial macrophages and alveolar epithelial cells 
(Tatarczuch et al., 1997). Both cell proliferation and 
apoptosis have been used clinically for assessment of 
tumor prognosis because there is a relationship between 
proliferation index and malignancy in many tumors 
(including breast cancer) and for the analysis of the 
response of cancer cells to clinical interventions 
(Beresford et al., 2006; Railo et al., 2006). Loading of 
tamoxifen inside SLN enhanced the treatment efficacy of 
tamoxifen and decreased its side effect on liver and 
biochemical serum parameters. However, further studies 
using clinical trials will be needed to determine if the 






The study showed that mammary gland tumors can 
easily be induced by subcutaneous injection of LA7 cells 
into the mammary pad of the female Sprague-Dawley 
rats. This method of tumor induction is safe, quick, 
economical and practical with tumor development occurring 
within 7 to 10 days of injection. This method eliminates 
the hazards associated with the use of carcinogens and 
immunosuppressive compounds. The histopathological 
and ultrastructural feature of the induced tumor resem-
bled that of the spontaneous mammary gland tumors and 
showed similarities to human breast cancers, particularly 
in morphological feature and cellular components. One of 
the main advantages of this tumor model is that it is 
easily reproducible. However, a previous study sug-
gested that the rat mammary gland tumor model rarely 
develop metastasis and expressed cell surface molecules 
different from the original tissue (Jacob et al., 2004). 
However, this may just be an evidence of mutation that 
could be a characteristic of tumors. In conclusion, this rat 
model can be applied for the study of breast cancers. 
This study also determined the effect of free TAM, TAM 
loaded-SLN and TAM-free SLN on the induced rat 
tumors. The result suggests that TAM-loaded SLN has 
similar effect on the tumor as free  TAM, which  promoted  
apoptosis in the rat mammary gland tumor. The efficacy 
of free-TAM and TAM-loaded SLN was similar. However, 
the TAM-loaded SLN showed a more prolonged effect 
suggesting that incorporation of TAM in SLN is suitable 
for delayed drug release in the chemotherapy of breast 





study suggests that TAM-loaded SLN is suitable for used 
as a new drug delivery system in the treatment of breast 
cancers. Thus, further studies are warranted to further 
develop and optimize this drug delivery system in the 
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